Lytus Technologies acquires Blod.in, an AI-powered on-demand blood logistics platform

Lytus Technologies, a multinational platform services company, has completed the acquisition of Blod.in, which it calls India’s first on-demand AI-powered blood component logistics platform.

The deal was finalized through Lytus HealthTech, the company’s dedicated healthcare arm, and marks a significant step in its plan to build a next-generation, AI-led healthcare infrastructure.

What does Blod.in do?

Currently operational in Chennai, Blod.in connects hospitals and blood banks through an advanced logistics system powered by artificial intelligence and machine learning. The platform streamlines the supply of critical blood components, aiming to reduce wait times, cut wastage, and ensure timely deliveries. With plans to expand to 100 more hospitals and 15 blood banks in the near term, the company is also targeting other major metros like Bengaluru, Mumbai, and Hyderabad, before taking the platform global.

Commenting on the milestone, Lytus Technologies CEO Dharmesh Pandya said, “Healthcare presents a powerful intersection of business growth and societal impact. At Lytus HealthTech, we are committed to building scalable solutions that seamlessly integrate advanced AI, ML, and Agentic AI to transform the future of blood and medical logistics. Our focus is on improving access, streamlining workflows, and delivering better patient outcomes across India.”

Blod.in’s growth trajectory has been steep, scaling from 30 to 140 hospitals within a year, with a 20% monthly growth rate. Its AI-powered technology—soon to be branded as Blod+—has shown the ability to reduce blood procurement time to as little as 90 minutes, addressing a national shortfall that results in 12,000 deaths per day due to lack of timely blood availability.

Lytus commits Rs 1,000 crore investment

Lytus has committed Rs 1,000 crore over the next three years to boost its digital healthcare offerings and expand operations both organically and through further acquisitions. A large part of this capital will go into developing Blod.in’s AI engine for real-time inventory mapping, delivery routing, and autonomous Agentic AI agents that can make decisions without human intervention.

Sai Guna Ranjan Puranam, COO of Lytus HealthTech, stated, “We are not just building a digital-first platform, we are building a community of healthcare providers, connected by trust, technology, and the shared mission to save lives. Our AI-first model enables proactive collaboration, not reactive firefighting — ensuring every patient, every hospital, and every unit of blood is accounted for with precision and care. We are uniquely positioned to solve critical challenges in patient care and medical logistics.”